205.
The National Institutes of Health intermittent positivepressure breath
ing trial: pathology studies / A Nagai., W.W West., J.B Paul., W.M Tluirbeek
Am Rev Respir Dis. - 1985. - V. 132. P. 937-945
206.
The role of nitric oxide and the renm-angiotensin system in salt
restricted Dahl rats / Kataoka H, Otsuka F, Ogura T et al. // H Am J Hyper-
tens. 2001. V. 14(3). - P.276-285.
207.
Tsukino M. Effects of theophylline and ipratropium bromide on exer
cise performance pulmonary disease / M. Tsukino // Thorax. - 1998. V 53
P. 269-273.
208.
Tutar E. Echocardiographic evaluation of leftventricular diastolic func
tion in chronic cor pulmonale / E. Tutar, A. Kaya, S. Gulec // Am. J. Cardiol. -
1999. - V. 83. - №9. - P. 1414-1417.
209.
Van Houwelingen K. The sleep apnoea syndromes / K. van Houwclin-
gen, R. van Uffelen, A. van Viet // Eur. Heart J. - 1999. - V. 20. - P. 858-866
210.
Van Noord J.A. longterm treatment of chronic obstructive pulmonary
disease with sahneterol and the additive effect of ipratropium / J.A. van
Noord, D R. de Munck., T.A. Bantje // Eur Respir J. - 2000. V. I5. P. 878-
885.
211.
Van Noord J.A. A randomized controlled comparison of tiotropium and
ipratropium in the treatment of chronic obstructive pulmonary disease. The
Dutch Tiotropium Study Group/ J.A. Van Noord., T.A. Bantje., M E. Eland
Thorax. - 2000. V. 55. - P. 289-294.
212.
Weitzenblum E. Hypoxic pulmonary hypertension in man: what mini
mum daily duration of hypoxaemia is required? / E. Weitzenblum, A.Chaouat
// Eur Respir J. - 2001. - V. 18. P. 251- 253.
213.
Wesseling G. A comparison of the effects of anticholinergic and be-
ta2agonist and combination therapy on respiratory impedance in COPD /
G. Wesseling // Chest. - 1992. - V . 101. - P . 166-173.
214.
Wincken W. On behalf of the Dutch/Belgian Tiotropium Study Group.
Improved health patients with COPD during lyrs treatment with tiotropium
140
